168 related articles for article (PubMed ID: 7693940)
1. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process.
Aho K; von Essen R; Kurki P; Palosuo T; Heliövaara M
J Rheumatol; 1993 Aug; 20(8):1278-81. PubMed ID: 7693940
[TBL] [Abstract][Full Text] [Related]
2. [Comparative characteristics of specific autoantibodies in rheumatoid arthritis].
Lapin SV; Maslianskiĭ AL; Mazurov VI; Totolian AA
Ter Arkh; 2005; 77(12):53-9. PubMed ID: 16514821
[TBL] [Abstract][Full Text] [Related]
3. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies.
Sebbag M; Simon M; Vincent C; Masson-Bessière C; Girbal E; Durieux JJ; Serre G
J Clin Invest; 1995 Jun; 95(6):2672-9. PubMed ID: 7539459
[TBL] [Abstract][Full Text] [Related]
4. Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis.
Saraux A; Berthelot JM; Devauchelle V; Bendaoud B; Chalès G; Le Henaff C; Thorel JB; Hoang S; Jousse S; Baron D; Le Goff P; Youinou P
J Rheumatol; 2003 Dec; 30(12):2535-9. PubMed ID: 14719190
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor.
Cordonnier C; Meyer O; Palazzo E; de Bandt M; Elias A; Nicaise P; Haïm T; Kahn MF; Chatellier G
Br J Rheumatol; 1996 Jul; 35(7):620-4. PubMed ID: 8670593
[TBL] [Abstract][Full Text] [Related]
6. Significance of antikeratin antibodies in rheumatoid arthritis.
Hajiroussou VJ; Skingle J; Gillett AP; Webley M
J Rheumatol; 1985 Feb; 12(1):57-9. PubMed ID: 2580092
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of antikeratin antibodies in rheumatoid arthritis.
Ordeig J; Guardia J
J Rheumatol; 1984 Oct; 11(5):602-4. PubMed ID: 6210364
[TBL] [Abstract][Full Text] [Related]
8. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A
Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426
[TBL] [Abstract][Full Text] [Related]
9. Prospect for an additional laboratory criterion for rheumatoid arthritis.
von Essen R; Kurki P; Isomäki H; Okubo S; Kautiainen H; Aho K
Scand J Rheumatol; 1993; 22(6):267-72. PubMed ID: 7505480
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F
J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis.
Janssens X; Veys EM; Verbruggen G; Declercq L
J Rheumatol; 1988 Sep; 15(9):1346-50. PubMed ID: 3058971
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of antikeratin antibodies in Greek patients with rheumatoid arthritis. A clinical, serologic, and immunogenetic study.
Boki KA; Kurki P; Holthofer H; Tzioufas AG; Drosos AA; Moutsopoulos HM
J Rheumatol; 1995 Nov; 22(11):2046-8. PubMed ID: 8596142
[TBL] [Abstract][Full Text] [Related]
13. Antiperinuclear factor: indicator of more severe disease in seronegative rheumatoid arthritis.
Westgeest AA; Boerbooms AM; Jongmans M; Vandenbroucke JP; Vierwinden G; van de Putte LB
J Rheumatol; 1987 Oct; 14(5):893-7. PubMed ID: 3501470
[TBL] [Abstract][Full Text] [Related]
14. Antiperinuclear factor and keratin antibodies in rheumatoid arthritis.
Johnson GD; Carvalho A; Holborow EJ; Goddard DH; Russell G
Ann Rheum Dis; 1981 Jun; 40(3):263-6. PubMed ID: 6166255
[TBL] [Abstract][Full Text] [Related]
15. An eight year prospective study of outcome prediction by antiperinuclear factor and antikeratin antibodies at onset of rheumatoid arthritis.
Genevay S; Hayem G; Verpillat P; Meyer O
Ann Rheum Dis; 2002 Aug; 61(8):734-6. PubMed ID: 12117683
[TBL] [Abstract][Full Text] [Related]
16. Antiperinuclear factor as a prognostic marker in rheumatoid arthritis.
Muñoz-Fernández S; Alvarez-Doforno R; González-Tarrio JM; Balsa A; Richi P; Fontán G; Gijón-Baños J; Martin-Mola E
J Rheumatol; 1999 Dec; 26(12):2572-7. PubMed ID: 10606364
[TBL] [Abstract][Full Text] [Related]
17. Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection.
Kessel A; Rosner I; Zuckerman E; Golan TD; Toubi E
J Rheumatol; 2000 Mar; 27(3):610-2. PubMed ID: 10743797
[TBL] [Abstract][Full Text] [Related]
18. Is it necessary to combine detection of anticitrullinated protein antibodies in the diagnosis of rheumatoid arthritis?
Zhao J; Liu X; Wang Z; Liu R; Li Z
J Rheumatol; 2010 Dec; 37(12):2462-5. PubMed ID: 20952480
[TBL] [Abstract][Full Text] [Related]
19. [Specific antibodies for the early diagnosis of rheumatoid arthritis].
Li H; Li X; Gan X
Zhonghua Yi Xue Za Zhi; 2000 Jan; 80(1):20-4. PubMed ID: 11798731
[TBL] [Abstract][Full Text] [Related]
20. Rheumatoid factors, anti-filaggrin antibodies and low in vitro interleukin-2 and interferon-gamma production are useful immunological markers for early diagnosis of community cases of rheumatoid arthritis. A preliminary study.
Vittecoq O; Jouen-Beades F; Krzanowska K; Bichon-Tauvel I; Ménard JF; Daragon A; Tron F; Le Loët X
Joint Bone Spine; 2001 Mar; 68(2):144-53. PubMed ID: 11324930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
